We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




INVITATION! Meet us at the Brazilian Society of Clinical Analysis 2023

By LabMedica International staff writers
Posted on 15 Jun 2023
Print article
Image
Image
Image
Image
Image
Image
We are pleased to announce Tianlong’s presence at the 48th Brazilian Society of Clinical Analysis, which presents a great opportunity for Tianlong to share our wealth of products and innovative technologies with the industry.

Brazilian Society of Clinical Analysis
DATES: 18 June – 21 June 2023
LOCATION: Costao do Santinho Resort, Florianopolis, Brazil
BOOTH: 69A+69B

Tianlong will be attending this event with our all-in-one molecular diagnosis system Panall 8000, our latest offering for PCR laboratory diagnostics.

Tianlong's newly launched Panall 8000 All-in-one Molecular Diagnosis System includes its self-developed full-automatic nucleic acid detection analysis system and a number of multi-pathogen nucleic acid detection kits. Based on the principle of Magnetic Beads method and real-time PCR reaction, Panall 8000 can be matched with compatible reagents for sample nucleic acid extraction, in vitro nucleic acid amplification and analysis in molecular detection. It is a simple and secure molecular diagnosis system that integrates the functions of sample tube decapping/capping, sample loading, nucleic acid extraction, PCR setup, PCR detection and result analysis, and can detect up to 24 target genes in a single sample with one reagent, which can realize a true “sample in -result out” detection process and bring great convenience for professionals with only one-key operation.
Panall 8000 can be widely used in community hospital, hospital emergency, CDC and research institute. With the compatible reagents, Panall 8000 can run parallel detections, including pathogen detections in respiratory disease, sexual transmitted disease, gastroenteric diseases, etc., to provide an overall solution for early and accurate identification of pathogenic microorganisms.



New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The new tests seek to detect mutant DNA in blood samples, indicating the presence of cancer cells (Photo courtesy of Christian Stolte/Weill Cornell)

Advanced Liquid Biopsy Technology Detects Cancer Earlier Than Conventional Methods

Liquid biopsy technology has yet to fully deliver on its significant potential. Traditional methods have focused on a narrow range of cancer-associated mutations that are often present in such low quantities... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.